Corebridge Financial’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-36,523
| Closed | -$1.48M | – | 103 |
|
2025
Q1 | $1.48M | Buy |
36,523
+2,817
| +8% | +$114K | 0.01% | 1103 |
|
2024
Q4 | $938K | Sell |
33,706
-2,544
| -7% | -$70.8K | 0.01% | 1354 |
|
2024
Q3 | $1.04M | Sell |
36,250
-223
| -0.6% | -$6.4K | 0.01% | 1343 |
|
2024
Q2 | $856K | Buy |
+36,473
| New | +$856K | ﹤0.01% | 1410 |
|